(Q43868203)

English

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database (English)

1 reference

Europe PubMed Central

27 November 2017

author name string

Schnitzer TJ

1

1 reference

Europe PubMed Central

27 November 2017

Kong SX

2

1 reference

Europe PubMed Central

27 November 2017

Mavros PP

3

1 reference

Europe PubMed Central

27 November 2017

Straus WL

4

1 reference

Europe PubMed Central

27 November 2017

Watson DJ

5

1 reference

Europe PubMed Central

27 November 2017

publication date

1 December 2001

1 reference

Europe PubMed Central

27 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

27 November 2017

23

1 reference

Europe PubMed Central

27 November 2017

12

1 reference

Europe PubMed Central

27 November 2017

1984-1998

1 reference

Europe PubMed Central

27 November 2017

The mode of action of aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ulcer complications and nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980151-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80151-X

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43868203&oldid=2104037067"